Cellective BioTherapy Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.5M
Latest Deal Amount
  • Investors
  • 2

Cellective BioTherapy General Information

Description

Developer of a biotechnology platform intended to revolutionize the way to treat immunological diseases. The company's platform provides the ability to expand human B cells for use as autologous cellular immunotherapy for treating cancers, autoimmunity and immunodeficiency, enabling physicians to treat patients without destroying essential B cells and their protective functions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6 Davis Drive
  • Research Triangle Park
  • Durham, NC 27709
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellective BioTherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 26-May-2015 $2.5M 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view Cellective BioTherapy’s complete valuation and funding history, request access »

Cellective BioTherapy Executive Team (2)

Name Title Board Seat Contact Info
Thomas Tedder Ph.D Founder, Chief Executive Officer and Board Member
Robert Bonczek JD Chief Financial Officer and Board Member
To view Cellective BioTherapy’s complete executive team members history, request access »

Cellective BioTherapy Board Members (3)

Name Representing Role Since
Fred Eshelman Eshelman Ventures Chairman 000 0000
Robert Bonczek JD Cellective BioTherapy Chief Financial Officer and Board Member 000 0000
Thomas Tedder Ph.D Cellective BioTherapy Founder, Chief Executive Officer and Board Member 000 0000
To view Cellective BioTherapy’s complete board members history, request access »

Cellective BioTherapy Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
MedBlue Accelerator/Incubator Minority 000 0000 000000 0
To view Cellective BioTherapy’s complete investors history, request access »